# Zanaflex

NDC: 70515-602
Generic name: tizanidine hydrochloride
Labeler / Manufacturer: Covis Pharma US, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20180801

FDA application: NDA021447

## Active ingredients

- TIZANIDINE HYDROCHLORIDE: 2 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70515-602"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70515-602
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=043d9e51-bfa2-4add-9058-5ece332f7e99